Met Janisha Tablet belongs to the category of medicines called “anti-diabetic” primarily used to treat type 2 diabetes, especially in persons whose sugar levels are too high and cannot be controlled by dieting and exercising. It is used alone or in combination with other drugs to lower blood sugar levels. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes, also known as adult-onset diabetes.

Met Janisha Tablet contains Teneligliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Met Janisha Tablet is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone 'Incretin'). The enzyme 'Incretins' helps produce more insulin only when required and reduces the liver's blood sugar level when not needed.

Take Met Janisha Tablet as prescribed. You are advised to use Met Janisha Tablet for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience certain common side effects such as headache, hypoglycemia (low blood glucose levels), upper respiratory tract infection, and nasopharyngitis (infection of the nose and throat with a common cold). Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Met Janisha Tablet should not be stopped even if you feel better, without consulting your doctor as sugar level keeps changing. If you stop taking Met Janisha Tablet abruptly, it may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy), and nerve damage (neuropathy). Please inform your doctor if you have any heart disease is or planning to get pregnant or breastfeed. The safety and efficacy of Met Janisha Tablet in children have not been established, so it should not be given to them. Met Janisha Tablet works best when coupled with a healthy lifestyle like losing weight if you are overweight (BMI>25), eating fewer calories (low fat and sugary food), and being more physically active (at least 150 min of activity every week).

Met Janisha Tablet contains ‘Teneligliptin’, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used to treat type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Met Janisha Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis. Thus, Met Janisha Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer, and delayed wound healing.

Met Janisha Tablet should not be taken if you are allergic to Met Janisha Tablet or any of its ingredients. Please inform your doctor if you are pregnant or breastfeeding before starting Met Janisha Tablet. The safety and efficacy of Met Janisha Tablet in children have not been established, so it should not be given to them. Prolonged intake of Met Janisha Tablet may cause acute pancreatitis (swollen pancreas). Increased risk of hypoglycemia (low blood sugar level) can occur when Met Janisha Tablet is added to other anti-diabetic agents or insulin therapy. In this case, your doctor may adjust the dose of Met Janisha Tablet. Severe allergic reactions might occur in some patients taking Met Janisha Tablet like anaphylaxis, angioedema (swelling under the skin), and exfoliative skin conditions. Met Janisha Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.